Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
MicroRNAs | 39 | 2023 | 3752 | 7.050 |
Why?
|
Kruppel-Like Transcription Factors | 18 | 2022 | 504 | 4.010 |
Why?
|
Endothelial Cells | 27 | 2023 | 3479 | 3.700 |
Why?
|
Atherosclerosis | 19 | 2024 | 3445 | 3.330 |
Why?
|
Early Growth Response Transcription Factors | 7 | 2022 | 29 | 3.070 |
Why?
|
Neovascularization, Physiologic | 10 | 2023 | 1351 | 2.530 |
Why?
|
Peripheral Arterial Disease | 10 | 2023 | 1188 | 1.760 |
Why?
|
Diabetes Mellitus, Experimental | 4 | 2023 | 1116 | 1.610 |
Why?
|
Plaque, Atherosclerotic | 7 | 2024 | 1519 | 1.590 |
Why?
|
Ischemia | 8 | 2023 | 1907 | 1.530 |
Why?
|
Vascular System Injuries | 3 | 2020 | 250 | 1.510 |
Why?
|
MAP Kinase Signaling System | 3 | 2022 | 1526 | 1.380 |
Why?
|
Arteries | 3 | 2020 | 1119 | 1.290 |
Why?
|
RNA, Untranslated | 3 | 2021 | 453 | 1.280 |
Why?
|
Myocytes, Smooth Muscle | 8 | 2022 | 687 | 1.270 |
Why?
|
Vasculitis | 5 | 2020 | 519 | 1.260 |
Why?
|
Signal Transduction | 35 | 2023 | 23403 | 1.180 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2020 | 697 | 1.130 |
Why?
|
Diabetic Cardiomyopathies | 2 | 2017 | 96 | 1.070 |
Why?
|
Transforming Growth Factor beta | 10 | 2023 | 2007 | 1.060 |
Why?
|
Neovascularization, Pathologic | 6 | 2021 | 2635 | 1.050 |
Why?
|
NF-kappa B | 9 | 2022 | 2499 | 1.050 |
Why?
|
Receptors, LDL | 3 | 2024 | 475 | 1.000 |
Why?
|
Smad1 Protein | 2 | 2016 | 81 | 1.000 |
Why?
|
T-Lymphocytes, Regulatory | 5 | 2022 | 2988 | 0.990 |
Why?
|
Animals | 83 | 2024 | 168757 | 0.970 |
Why?
|
Diabetes Mellitus | 8 | 2024 | 5751 | 0.950 |
Why?
|
Wound Healing | 3 | 2020 | 2785 | 0.940 |
Why?
|
Mice | 54 | 2024 | 81183 | 0.910 |
Why?
|
Macrophages | 16 | 2024 | 5655 | 0.910 |
Why?
|
Cardiovascular Diseases | 9 | 2022 | 15165 | 0.910 |
Why?
|
Muscle, Smooth, Vascular | 7 | 2021 | 1504 | 0.900 |
Why?
|
Carotid Artery Diseases | 2 | 2021 | 882 | 0.850 |
Why?
|
Endothelium, Vascular | 9 | 2022 | 4456 | 0.850 |
Why?
|
Diabetic Angiopathies | 2 | 2017 | 818 | 0.810 |
Why?
|
Gene Expression Regulation | 22 | 2021 | 12072 | 0.800 |
Why?
|
Serum Response Factor | 2 | 2021 | 81 | 0.800 |
Why?
|
MAP Kinase Kinase Kinase 4 | 1 | 2020 | 4 | 0.780 |
Why?
|
Tunica Intima | 4 | 2022 | 464 | 0.760 |
Why?
|
Inflammation | 14 | 2022 | 10638 | 0.740 |
Why?
|
Aortic Diseases | 2 | 2024 | 742 | 0.730 |
Why?
|
DNA-Activated Protein Kinase | 1 | 2020 | 117 | 0.700 |
Why?
|
Antirheumatic Agents | 4 | 2023 | 1339 | 0.700 |
Why?
|
Oligonucleotides, Antisense | 3 | 2020 | 433 | 0.670 |
Why?
|
Methotrexate | 4 | 2023 | 1727 | 0.670 |
Why?
|
Mice, Inbred C57BL | 17 | 2024 | 21827 | 0.650 |
Why?
|
Monocytes | 9 | 2017 | 2596 | 0.650 |
Why?
|
Bone Marrow Cells | 5 | 2013 | 2513 | 0.630 |
Why?
|
CD4-Positive T-Lymphocytes | 5 | 2022 | 4386 | 0.620 |
Why?
|
Snow | 1 | 2017 | 16 | 0.620 |
Why?
|
RNA, Small Nucleolar | 1 | 2017 | 31 | 0.610 |
Why?
|
Insulin Resistance | 4 | 2021 | 3864 | 0.590 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 2 | 2016 | 323 | 0.590 |
Why?
|
Interferons | 1 | 2020 | 706 | 0.580 |
Why?
|
Nitric Oxide Synthase Type III | 3 | 2019 | 689 | 0.580 |
Why?
|
Cell Proliferation | 11 | 2022 | 10481 | 0.580 |
Why?
|
Genome, Viral | 1 | 2020 | 667 | 0.580 |
Why?
|
Myeloid Progenitor Cells | 3 | 2011 | 111 | 0.550 |
Why?
|
Transforming Growth Factor beta1 | 6 | 2011 | 644 | 0.550 |
Why?
|
Tamoxifen | 1 | 2020 | 981 | 0.540 |
Why?
|
Oxidative Stress | 2 | 2020 | 3086 | 0.540 |
Why?
|
Mice, Knockout | 13 | 2024 | 14557 | 0.540 |
Why?
|
Intracellular Signaling Peptides and Proteins | 3 | 2021 | 2915 | 0.540 |
Why?
|
Adenosine | 1 | 2021 | 825 | 0.540 |
Why?
|
Aorta | 6 | 2022 | 2061 | 0.530 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2020 | 1285 | 0.530 |
Why?
|
Adaptive Immunity | 1 | 2020 | 713 | 0.520 |
Why?
|
Serine Endopeptidases | 1 | 2020 | 1072 | 0.510 |
Why?
|
Phosphofructokinase-2 | 1 | 2015 | 32 | 0.510 |
Why?
|
Gene Expression Profiling | 4 | 2022 | 9438 | 0.510 |
Why?
|
Granulocyte-Macrophage Progenitor Cells | 2 | 2011 | 21 | 0.510 |
Why?
|
CARD Signaling Adaptor Proteins | 1 | 2016 | 156 | 0.510 |
Why?
|
N-Ethylmaleimide-Sensitive Proteins | 1 | 2014 | 9 | 0.500 |
Why?
|
NF-kappa B p50 Subunit | 2 | 2012 | 107 | 0.500 |
Why?
|
Fatty Liver | 1 | 2020 | 727 | 0.500 |
Why?
|
RNA, Messenger | 9 | 2022 | 13033 | 0.480 |
Why?
|
Immunologic Memory | 3 | 2020 | 1348 | 0.470 |
Why?
|
Cell Differentiation | 8 | 2022 | 11483 | 0.470 |
Why?
|
Thrombin | 1 | 2016 | 598 | 0.460 |
Why?
|
Lipoproteins, VLDL | 1 | 2014 | 201 | 0.450 |
Why?
|
Receptors, Transforming Growth Factor beta | 1 | 2015 | 314 | 0.450 |
Why?
|
Epigenesis, Genetic | 3 | 2021 | 3647 | 0.450 |
Why?
|
Humans | 91 | 2024 | 744343 | 0.450 |
Why?
|
Adipose Tissue, White | 1 | 2016 | 351 | 0.440 |
Why?
|
Myocardial Infarction | 7 | 2023 | 11727 | 0.440 |
Why?
|
Carotid Artery Injuries | 1 | 2013 | 96 | 0.430 |
Why?
|
Cell Nucleus | 2 | 2020 | 2969 | 0.420 |
Why?
|
Coxsackievirus Infections | 1 | 2012 | 44 | 0.420 |
Why?
|
DNA-Binding Proteins | 12 | 2011 | 9648 | 0.420 |
Why?
|
Veins | 1 | 2016 | 770 | 0.410 |
Why?
|
Blood Vessels | 1 | 2018 | 1125 | 0.410 |
Why?
|
Paracrine Communication | 1 | 2013 | 277 | 0.400 |
Why?
|
Trans-Activators | 8 | 2007 | 2924 | 0.400 |
Why?
|
Arthritis, Rheumatoid | 3 | 2023 | 3712 | 0.400 |
Why?
|
Coronary Restenosis | 1 | 2014 | 424 | 0.400 |
Why?
|
Myocardial Ischemia | 2 | 2020 | 2148 | 0.390 |
Why?
|
Diabetes Complications | 1 | 2018 | 1359 | 0.390 |
Why?
|
DNA Damage | 2 | 2020 | 2432 | 0.380 |
Why?
|
Cardiovascular System | 2 | 2017 | 832 | 0.380 |
Why?
|
Apolipoproteins E | 3 | 2013 | 1438 | 0.370 |
Why?
|
Adipose Tissue | 4 | 2020 | 3279 | 0.370 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2019 | 2503 | 0.370 |
Why?
|
Transcription Factors | 10 | 2023 | 12208 | 0.360 |
Why?
|
Coronary Artery Disease | 3 | 2021 | 6487 | 0.360 |
Why?
|
Diabetic Nephropathies | 1 | 2017 | 984 | 0.350 |
Why?
|
Gene Knockdown Techniques | 3 | 2022 | 1655 | 0.350 |
Why?
|
Mechanotransduction, Cellular | 1 | 2015 | 541 | 0.350 |
Why?
|
Cell Line | 14 | 2021 | 15997 | 0.340 |
Why?
|
Diabetes Mellitus, Type 2 | 4 | 2023 | 11725 | 0.340 |
Why?
|
Wounds, Nonpenetrating | 1 | 2016 | 794 | 0.340 |
Why?
|
Myocytes, Cardiac | 4 | 2022 | 1637 | 0.320 |
Why?
|
Bone Morphogenetic Proteins | 1 | 2013 | 838 | 0.320 |
Why?
|
Interleukin-2 Receptor alpha Subunit | 1 | 2009 | 310 | 0.310 |
Why?
|
Drug Discovery | 2 | 2017 | 1058 | 0.310 |
Why?
|
Obesity | 4 | 2021 | 12745 | 0.300 |
Why?
|
Cell Movement | 4 | 2021 | 5217 | 0.290 |
Why?
|
Triglycerides | 2 | 2014 | 2454 | 0.280 |
Why?
|
Ventricular Remodeling | 1 | 2014 | 1224 | 0.280 |
Why?
|
Chemotaxis | 2 | 2024 | 607 | 0.280 |
Why?
|
Vaccinia virus | 1 | 2008 | 349 | 0.280 |
Why?
|
Cytokines | 8 | 2022 | 7322 | 0.280 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2014 | 2073 | 0.280 |
Why?
|
Forkhead Transcription Factors | 2 | 2013 | 1613 | 0.270 |
Why?
|
Homeostasis | 2 | 2021 | 3340 | 0.270 |
Why?
|
Leukocytes | 2 | 2012 | 2043 | 0.270 |
Why?
|
Molecular Targeted Therapy | 1 | 2017 | 2727 | 0.260 |
Why?
|
Leukocytes, Mononuclear | 3 | 2022 | 1836 | 0.260 |
Why?
|
Vascular Diseases | 1 | 2013 | 1161 | 0.250 |
Why?
|
Smad Proteins | 1 | 2005 | 162 | 0.250 |
Why?
|
Aging | 1 | 2024 | 8664 | 0.250 |
Why?
|
Myocardium | 2 | 2022 | 4776 | 0.250 |
Why?
|
Myocarditis | 1 | 2012 | 771 | 0.250 |
Why?
|
Stem Cells | 2 | 2020 | 3567 | 0.250 |
Why?
|
Cytotoxicity, Immunologic | 2 | 2008 | 1369 | 0.250 |
Why?
|
Vascular Endothelial Growth Factor A | 4 | 2023 | 3508 | 0.240 |
Why?
|
Male | 35 | 2023 | 350118 | 0.240 |
Why?
|
Antigen Presentation | 2 | 2008 | 1284 | 0.240 |
Why?
|
Smad3 Protein | 5 | 2005 | 180 | 0.240 |
Why?
|
Transcription Factor RelA | 2 | 2021 | 275 | 0.230 |
Why?
|
Energy Metabolism | 1 | 2015 | 2899 | 0.230 |
Why?
|
Macrophage Activation | 6 | 2008 | 558 | 0.230 |
Why?
|
Gene Silencing | 3 | 2020 | 1538 | 0.220 |
Why?
|
Transforming Growth Factors | 1 | 2022 | 76 | 0.220 |
Why?
|
Factor X | 1 | 2022 | 64 | 0.220 |
Why?
|
Inhibins | 1 | 2023 | 211 | 0.220 |
Why?
|
Regional Blood Flow | 2 | 2020 | 1525 | 0.210 |
Why?
|
Muscle, Skeletal | 5 | 2022 | 4931 | 0.210 |
Why?
|
Interleukin-9 | 1 | 2022 | 63 | 0.210 |
Why?
|
Hypertension | 1 | 2022 | 8480 | 0.200 |
Why?
|
RNA | 2 | 2022 | 2749 | 0.200 |
Why?
|
Genetic Markers | 2 | 2020 | 2634 | 0.200 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2015 | 4479 | 0.200 |
Why?
|
Arteriosclerosis | 5 | 2007 | 1092 | 0.200 |
Why?
|
RNA, Small Interfering | 4 | 2023 | 3505 | 0.200 |
Why?
|
Blood Glucose | 1 | 2016 | 6256 | 0.200 |
Why?
|
Chemokine CCL2 | 1 | 2004 | 617 | 0.190 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2020 | 9 | 0.190 |
Why?
|
Transforming Growth Factor beta3 | 1 | 2020 | 44 | 0.190 |
Why?
|
Neutrophils | 1 | 2013 | 3719 | 0.180 |
Why?
|
Swine | 2 | 2020 | 5917 | 0.180 |
Why?
|
Cells, Cultured | 9 | 2020 | 19229 | 0.180 |
Why?
|
Complement Activation | 1 | 2022 | 453 | 0.180 |
Why?
|
Phosphorylation | 4 | 2019 | 8436 | 0.180 |
Why?
|
Phosphatidylinositol 3-Kinase | 1 | 2020 | 130 | 0.180 |
Why?
|
Fibroblasts | 3 | 2016 | 4161 | 0.180 |
Why?
|
I-kappa B Kinase | 1 | 2021 | 252 | 0.180 |
Why?
|
Metalloendopeptidases | 2 | 2000 | 396 | 0.170 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 2 | 2013 | 546 | 0.170 |
Why?
|
Hindlimb | 2 | 2011 | 504 | 0.170 |
Why?
|
Polypyrimidine Tract-Binding Protein | 1 | 2019 | 26 | 0.170 |
Why?
|
Tumor Suppressor Proteins | 2 | 2020 | 2849 | 0.170 |
Why?
|
Sus scrofa | 1 | 2021 | 437 | 0.170 |
Why?
|
Promoter Regions, Genetic | 11 | 2011 | 5867 | 0.170 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2022 | 555 | 0.170 |
Why?
|
Necrosis | 1 | 2023 | 1643 | 0.170 |
Why?
|
Angiotensin II | 1 | 2022 | 881 | 0.170 |
Why?
|
Repressor Proteins | 3 | 2004 | 3023 | 0.160 |
Why?
|
Inflammation Mediators | 3 | 2018 | 1889 | 0.160 |
Why?
|
Research Report | 1 | 2021 | 355 | 0.160 |
Why?
|
Angiogenic Proteins | 1 | 2018 | 104 | 0.160 |
Why?
|
Gene Targeting | 1 | 2021 | 880 | 0.160 |
Why?
|
Intermittent Claudication | 1 | 2020 | 309 | 0.160 |
Why?
|
Ebola Vaccines | 1 | 2017 | 24 | 0.150 |
Why?
|
Interleukin-10 | 2 | 2022 | 1200 | 0.150 |
Why?
|
Retinal Diseases | 1 | 2023 | 683 | 0.150 |
Why?
|
Organ Culture Techniques | 1 | 2020 | 813 | 0.150 |
Why?
|
Hypercholesterolemia | 2 | 2021 | 1151 | 0.150 |
Why?
|
Nitric Oxide Synthase Type II | 5 | 2007 | 534 | 0.150 |
Why?
|
Lipopolysaccharides | 5 | 2021 | 2216 | 0.150 |
Why?
|
Species Specificity | 2 | 2020 | 2478 | 0.150 |
Why?
|
Glucose | 3 | 2021 | 4397 | 0.140 |
Why?
|
Autoimmune Diseases | 2 | 2021 | 2133 | 0.140 |
Why?
|
Dendritic Cells | 1 | 2008 | 2725 | 0.140 |
Why?
|
Congresses as Topic | 1 | 2021 | 764 | 0.140 |
Why?
|
Codon, Terminator | 1 | 2017 | 127 | 0.140 |
Why?
|
STAT3 Transcription Factor | 1 | 2021 | 873 | 0.140 |
Why?
|
Constriction, Pathologic | 1 | 2020 | 1107 | 0.140 |
Why?
|
Estrogen Receptor alpha | 1 | 2020 | 577 | 0.140 |
Why?
|
Cell Cycle Proteins | 4 | 2023 | 3462 | 0.140 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2126 | 0.140 |
Why?
|
Inhibitor of Differentiation Protein 1 | 1 | 2016 | 47 | 0.140 |
Why?
|
Disease Models, Animal | 5 | 2021 | 18029 | 0.140 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2023 | 4420 | 0.140 |
Why?
|
Chromatography, Liquid | 1 | 2020 | 976 | 0.140 |
Why?
|
Viral Proteins | 2 | 2020 | 1900 | 0.140 |
Why?
|
Carotid Arteries | 2 | 2017 | 952 | 0.140 |
Why?
|
Arthritis | 1 | 2021 | 659 | 0.130 |
Why?
|
Adipose Tissue, Brown | 1 | 2021 | 757 | 0.130 |
Why?
|
Gene Regulatory Networks | 2 | 2021 | 1708 | 0.130 |
Why?
|
Neoplasms | 2 | 2022 | 21683 | 0.130 |
Why?
|
American Heart Association | 1 | 2020 | 1056 | 0.130 |
Why?
|
Fibrosis | 1 | 2022 | 2029 | 0.130 |
Why?
|
Transfection | 7 | 2007 | 5892 | 0.130 |
Why?
|
Mice, Obese | 1 | 2016 | 424 | 0.130 |
Why?
|
Gene Expression Regulation, Neoplastic | 3 | 2020 | 8428 | 0.130 |
Why?
|
Thoracic Outlet Syndrome | 1 | 2016 | 85 | 0.130 |
Why?
|
Immune System | 1 | 2020 | 805 | 0.130 |
Why?
|
Communicable Diseases, Emerging | 1 | 2017 | 157 | 0.130 |
Why?
|
Research Personnel | 1 | 2020 | 573 | 0.130 |
Why?
|
Protein Transport | 1 | 2020 | 1988 | 0.130 |
Why?
|
Ebolavirus | 1 | 2017 | 263 | 0.120 |
Why?
|
Phenotype | 3 | 2021 | 16365 | 0.120 |
Why?
|
Dermis | 1 | 2016 | 207 | 0.120 |
Why?
|
Immunoprecipitation | 1 | 2017 | 905 | 0.120 |
Why?
|
Gene Deletion | 2 | 2017 | 2751 | 0.120 |
Why?
|
Disease Progression | 4 | 2023 | 13284 | 0.120 |
Why?
|
Mice, Inbred NOD | 1 | 2019 | 1878 | 0.120 |
Why?
|
T-Lymphocytes, Cytotoxic | 6 | 2001 | 1821 | 0.120 |
Why?
|
Transcription, Genetic | 8 | 2021 | 7722 | 0.120 |
Why?
|
Peptide Fragments | 3 | 2021 | 5097 | 0.120 |
Why?
|
Gap Junctions | 1 | 2015 | 233 | 0.120 |
Why?
|
Tandem Mass Spectrometry | 1 | 2020 | 1157 | 0.120 |
Why?
|
Critical Illness | 2 | 2020 | 2670 | 0.110 |
Why?
|
Estrogens | 1 | 2020 | 1566 | 0.110 |
Why?
|
Receptors, CCR4 | 1 | 2013 | 81 | 0.110 |
Why?
|
Computer-Aided Design | 1 | 2015 | 298 | 0.110 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2021 | 1573 | 0.110 |
Why?
|
Transcription Factor AP-1 | 3 | 2006 | 317 | 0.110 |
Why?
|
Karyopherins | 1 | 2013 | 137 | 0.110 |
Why?
|
Severity of Illness Index | 3 | 2021 | 15540 | 0.110 |
Why?
|
Protein Kinases | 1 | 2020 | 1640 | 0.110 |
Why?
|
alpha Karyopherins | 1 | 2012 | 41 | 0.110 |
Why?
|
Nitric Oxide Synthase | 4 | 2004 | 916 | 0.110 |
Why?
|
Models, Biological | 3 | 2020 | 9583 | 0.110 |
Why?
|
Hemorrhagic Fever, Ebola | 1 | 2017 | 428 | 0.100 |
Why?
|
Female | 18 | 2023 | 380194 | 0.100 |
Why?
|
E-Selectin | 2 | 2012 | 579 | 0.100 |
Why?
|
Endarterectomy, Carotid | 1 | 2017 | 546 | 0.100 |
Why?
|
Culture Media, Conditioned | 1 | 2013 | 537 | 0.100 |
Why?
|
Gene Expression | 3 | 2016 | 7799 | 0.100 |
Why?
|
Antigens, CD34 | 1 | 2013 | 657 | 0.100 |
Why?
|
Blood Sedimentation | 2 | 2022 | 231 | 0.100 |
Why?
|
Lipoproteins | 1 | 2016 | 878 | 0.100 |
Why?
|
Epidemics | 1 | 2017 | 523 | 0.100 |
Why?
|
Endotoxemia | 1 | 2012 | 207 | 0.090 |
Why?
|
Molecular Structure | 1 | 2015 | 1899 | 0.090 |
Why?
|
Structure-Activity Relationship | 2 | 2015 | 3129 | 0.090 |
Why?
|
Lipid Metabolism | 2 | 2017 | 1889 | 0.090 |
Why?
|
Muscle Proteins | 3 | 2002 | 1159 | 0.090 |
Why?
|
Apoptosis | 3 | 2020 | 9727 | 0.090 |
Why?
|
Bone Marrow Transplantation | 2 | 2019 | 2765 | 0.090 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 2012 | 707 | 0.090 |
Why?
|
Hemodynamics | 1 | 2020 | 4199 | 0.090 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2023 | 2208 | 0.090 |
Why?
|
CCAAT-Enhancer-Binding Protein-delta | 3 | 2004 | 27 | 0.090 |
Why?
|
Small Molecule Libraries | 1 | 2015 | 720 | 0.080 |
Why?
|
T-Lymphocytes | 4 | 2008 | 10180 | 0.080 |
Why?
|
Embryonic Development | 1 | 2013 | 711 | 0.080 |
Why?
|
Immunity, Innate | 1 | 2020 | 2958 | 0.080 |
Why?
|
Tumor Suppressor Protein p53 | 1 | 2019 | 2948 | 0.080 |
Why?
|
Mast Cells | 1 | 2016 | 1544 | 0.080 |
Why?
|
Acute Lung Injury | 1 | 2012 | 380 | 0.080 |
Why?
|
Computational Biology | 1 | 2020 | 3521 | 0.080 |
Why?
|
Liver | 2 | 2021 | 7474 | 0.080 |
Why?
|
Receptors, Prostaglandin E | 1 | 2008 | 56 | 0.080 |
Why?
|
Vaccines | 1 | 2017 | 822 | 0.080 |
Why?
|
p300-CBP Transcription Factors | 2 | 2006 | 147 | 0.080 |
Why?
|
Risk Factors | 4 | 2023 | 72290 | 0.080 |
Why?
|
Nucleoproteins | 1 | 2008 | 115 | 0.080 |
Why?
|
RNA-Binding Proteins | 1 | 2017 | 1903 | 0.080 |
Why?
|
Mitochondria | 1 | 2020 | 3520 | 0.080 |
Why?
|
Smallpox Vaccine | 1 | 2008 | 80 | 0.080 |
Why?
|
CCAAT-Enhancer-Binding Proteins | 3 | 2004 | 286 | 0.080 |
Why?
|
Coculture Techniques | 1 | 2011 | 1341 | 0.080 |
Why?
|
Aspirin | 1 | 2019 | 3282 | 0.070 |
Why?
|
Hematopoietic System | 1 | 2007 | 109 | 0.070 |
Why?
|
RNA Interference | 1 | 2016 | 2889 | 0.070 |
Why?
|
Prognosis | 2 | 2020 | 29063 | 0.070 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1239 | 0.070 |
Why?
|
HLA-A2 Antigen | 2 | 1998 | 213 | 0.070 |
Why?
|
Protein Binding | 4 | 2008 | 9386 | 0.070 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2019 | 3068 | 0.070 |
Why?
|
Receptors, CXCR3 | 1 | 2007 | 237 | 0.070 |
Why?
|
Interferon-gamma | 3 | 2005 | 3206 | 0.070 |
Why?
|
Chick Embryo | 1 | 2008 | 982 | 0.070 |
Why?
|
Chemokines, CXC | 1 | 2007 | 422 | 0.070 |
Why?
|
Simian Acquired Immunodeficiency Syndrome | 2 | 2001 | 570 | 0.070 |
Why?
|
Nitrites | 1 | 2005 | 160 | 0.060 |
Why?
|
Angioplasty, Balloon, Coronary | 2 | 2005 | 1873 | 0.060 |
Why?
|
Blotting, Western | 2 | 2005 | 5179 | 0.060 |
Why?
|
Transcriptional Activation | 3 | 2007 | 1783 | 0.060 |
Why?
|
Time Factors | 7 | 2013 | 40075 | 0.060 |
Why?
|
Digitalis | 1 | 2004 | 14 | 0.060 |
Why?
|
Digitoxin | 1 | 2004 | 22 | 0.060 |
Why?
|
Plant Poisoning | 1 | 2004 | 13 | 0.060 |
Why?
|
Simian immunodeficiency virus | 2 | 2001 | 846 | 0.060 |
Why?
|
Chemotaxis, Leukocyte | 1 | 2007 | 675 | 0.060 |
Why?
|
Models, Molecular | 1 | 2015 | 5456 | 0.060 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2015 | 10943 | 0.060 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2005 | 281 | 0.060 |
Why?
|
Binding Sites | 2 | 2005 | 6114 | 0.060 |
Why?
|
Stem Cell Transplantation | 1 | 2013 | 1620 | 0.060 |
Why?
|
Immunoglobulin G | 1 | 2016 | 4560 | 0.060 |
Why?
|
Biomedical Research | 1 | 2020 | 3309 | 0.060 |
Why?
|
Matrix Metalloproteinase 12 | 2 | 2000 | 49 | 0.060 |
Why?
|
Thrombosis | 2 | 2016 | 2968 | 0.060 |
Why?
|
Blotting, Northern | 1 | 2005 | 1581 | 0.060 |
Why?
|
DNA | 3 | 2007 | 7301 | 0.060 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2017 | 4751 | 0.060 |
Why?
|
Pulmonary Embolism | 1 | 2016 | 2376 | 0.060 |
Why?
|
Cell Separation | 1 | 2009 | 1751 | 0.060 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2023 | 85 | 0.060 |
Why?
|
Immunophenotyping | 1 | 2008 | 1880 | 0.060 |
Why?
|
Up-Regulation | 3 | 2021 | 4217 | 0.060 |
Why?
|
Genetic Testing | 1 | 2016 | 3444 | 0.050 |
Why?
|
Bradycardia | 1 | 2004 | 307 | 0.050 |
Why?
|
HIV Antigens | 3 | 1998 | 347 | 0.050 |
Why?
|
Ventricular Function, Left | 2 | 2013 | 3670 | 0.050 |
Why?
|
Drug Therapy, Combination | 2 | 2023 | 6489 | 0.050 |
Why?
|
Tissue Distribution | 2 | 2023 | 2327 | 0.050 |
Why?
|
Complement Membrane Attack Complex | 1 | 2022 | 112 | 0.050 |
Why?
|
Zebrafish | 1 | 2013 | 2994 | 0.050 |
Why?
|
Adiponectin | 1 | 2007 | 1100 | 0.050 |
Why?
|
Biology | 1 | 2023 | 294 | 0.050 |
Why?
|
RNA, Small Untranslated | 1 | 2021 | 76 | 0.050 |
Why?
|
Down-Regulation | 2 | 2005 | 3002 | 0.050 |
Why?
|
Hematopoiesis | 1 | 2010 | 2072 | 0.050 |
Why?
|
Mutagenesis, Site-Directed | 2 | 2002 | 1723 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2002 | 440 | 0.050 |
Why?
|
Hyperplasia | 1 | 2004 | 1185 | 0.050 |
Why?
|
Rats | 3 | 2007 | 24260 | 0.050 |
Why?
|
Genes, Reporter | 2 | 2004 | 1547 | 0.050 |
Why?
|
Cell Culture Techniques | 1 | 2008 | 1678 | 0.050 |
Why?
|
High Mobility Group Proteins | 1 | 2001 | 187 | 0.050 |
Why?
|
Transplantation, Homologous | 3 | 2004 | 4776 | 0.050 |
Why?
|
Lymphocyte Activation | 3 | 2008 | 5524 | 0.050 |
Why?
|
Angiopoietin-2 | 1 | 2021 | 173 | 0.040 |
Why?
|
HIV Seropositivity | 2 | 2017 | 971 | 0.040 |
Why?
|
Enzyme Induction | 1 | 2000 | 475 | 0.040 |
Why?
|
Acute Coronary Syndrome | 1 | 2013 | 2337 | 0.040 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15076 | 0.040 |
Why?
|
Integrins | 1 | 2004 | 846 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2022 | 3778 | 0.040 |
Why?
|
Middle Aged | 10 | 2022 | 213383 | 0.040 |
Why?
|
Aged | 6 | 2023 | 163280 | 0.040 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2004 | 1155 | 0.040 |
Why?
|
Aged, 80 and over | 2 | 2022 | 57776 | 0.040 |
Why?
|
Nuclear Proteins | 4 | 2023 | 5853 | 0.040 |
Why?
|
Genetic Predisposition to Disease | 1 | 2020 | 17446 | 0.040 |
Why?
|
Cyclin D1 | 1 | 2021 | 463 | 0.040 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2020 | 1213 | 0.040 |
Why?
|
Flow Cytometry | 1 | 2009 | 5974 | 0.040 |
Why?
|
Antigenic Variation | 1 | 1998 | 125 | 0.040 |
Why?
|
Cell Lineage | 1 | 2007 | 2504 | 0.040 |
Why?
|
HIV-1 | 4 | 1998 | 6939 | 0.040 |
Why?
|
Recombinant Fusion Proteins | 2 | 2004 | 3772 | 0.040 |
Why?
|
Genetic Vectors | 1 | 2008 | 3420 | 0.040 |
Why?
|
Protein Structure, Tertiary | 1 | 2005 | 3846 | 0.040 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 3870 | 0.040 |
Why?
|
HLA-A Antigens | 1 | 1998 | 231 | 0.040 |
Why?
|
RNA-Directed DNA Polymerase | 2 | 1996 | 248 | 0.040 |
Why?
|
Endothelium | 1 | 2021 | 778 | 0.040 |
Why?
|
HIV Long-Term Survivors | 1 | 1998 | 126 | 0.040 |
Why?
|
Gene Products, gag | 1 | 1998 | 337 | 0.040 |
Why?
|
Troponin T | 1 | 2023 | 754 | 0.040 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 1 | 2002 | 871 | 0.040 |
Why?
|
Vesiculovirus | 1 | 2017 | 50 | 0.040 |
Why?
|
Amino Acid Sequence | 8 | 2004 | 13815 | 0.040 |
Why?
|
Genes, Dominant | 1 | 2000 | 880 | 0.040 |
Why?
|
Benzhydryl Compounds | 1 | 2023 | 845 | 0.040 |
Why?
|
Liberia | 1 | 2017 | 167 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2017 | 229 | 0.040 |
Why?
|
Cell Line, Tumor | 2 | 2019 | 16689 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2002 | 1081 | 0.040 |
Why?
|
Mice, Transgenic | 1 | 2009 | 9734 | 0.040 |
Why?
|
Transplantation Immunology | 1 | 1999 | 546 | 0.040 |
Why?
|
Epitopes | 3 | 1998 | 2571 | 0.040 |
Why?
|
Molecular Sequence Data | 8 | 2004 | 18111 | 0.040 |
Why?
|
Microfilament Proteins | 2 | 2002 | 1152 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-mdm2 | 1 | 2019 | 380 | 0.030 |
Why?
|
P-Selectin | 1 | 1999 | 600 | 0.030 |
Why?
|
Injections, Intramuscular | 1 | 2017 | 552 | 0.030 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2170 | 0.030 |
Why?
|
Neural Crest | 1 | 1998 | 275 | 0.030 |
Why?
|
Advisory Committees | 1 | 2020 | 775 | 0.030 |
Why?
|
Research Support as Topic | 1 | 2020 | 705 | 0.030 |
Why?
|
Lower Extremity | 1 | 2023 | 1158 | 0.030 |
Why?
|
Cholesterol, HDL | 1 | 2022 | 1814 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2021 | 21746 | 0.030 |
Why?
|
Medicare | 2 | 2023 | 6566 | 0.030 |
Why?
|
Proto-Oncogene Proteins | 1 | 2007 | 4554 | 0.030 |
Why?
|
Cell Adhesion Molecules | 1 | 2021 | 1602 | 0.030 |
Why?
|
DNA Primers | 4 | 2004 | 2892 | 0.030 |
Why?
|
Histocompatibility Antigens Class II | 1 | 1999 | 1475 | 0.030 |
Why?
|
Plasmids | 1 | 2019 | 2307 | 0.030 |
Why?
|
Muscle, Smooth | 1 | 1998 | 934 | 0.030 |
Why?
|
Drug Administration Schedule | 1 | 2022 | 4933 | 0.030 |
Why?
|
Stents | 1 | 2005 | 3280 | 0.030 |
Why?
|
Adenoviridae | 1 | 2017 | 1099 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1180 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 1999 | 1366 | 0.030 |
Why?
|
Cholesterol, LDL | 1 | 2022 | 2356 | 0.030 |
Why?
|
RNA, Viral | 2 | 2017 | 2902 | 0.030 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 2 | 2002 | 130 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3200 | 0.030 |
Why?
|
Oxygen | 1 | 2023 | 4189 | 0.030 |
Why?
|
Risk Assessment | 2 | 2023 | 23338 | 0.030 |
Why?
|
HEK293 Cells | 1 | 2021 | 4204 | 0.030 |
Why?
|
Base Sequence | 5 | 2004 | 12797 | 0.020 |
Why?
|
Heart Failure | 1 | 2015 | 10900 | 0.020 |
Why?
|
Cercocebus atys | 2 | 2001 | 12 | 0.020 |
Why?
|
Coronary Disease | 1 | 2005 | 6077 | 0.020 |
Why?
|
Electrocardiography | 2 | 2004 | 6442 | 0.020 |
Why?
|
3T3 Cells | 2 | 2002 | 1101 | 0.020 |
Why?
|
Heart Transplantation | 1 | 2004 | 3110 | 0.020 |
Why?
|
Stress, Mechanical | 2 | 2007 | 1686 | 0.020 |
Why?
|
Drug Delivery Systems | 1 | 2021 | 2219 | 0.020 |
Why?
|
Clinical Competence | 1 | 2005 | 4687 | 0.020 |
Why?
|
Fever | 1 | 2017 | 1616 | 0.020 |
Why?
|
Communicable Disease Control | 1 | 2017 | 857 | 0.020 |
Why?
|
United States | 3 | 2023 | 69872 | 0.020 |
Why?
|
Headache | 1 | 2017 | 1226 | 0.020 |
Why?
|
Phagocytosis | 2 | 2006 | 1539 | 0.020 |
Why?
|
DNA Repair | 1 | 2019 | 2046 | 0.020 |
Why?
|
Zinc Fingers | 2 | 2004 | 585 | 0.020 |
Why?
|
Interleukin-1 | 2 | 2004 | 1263 | 0.020 |
Why?
|
Treatment Outcome | 4 | 2023 | 63114 | 0.020 |
Why?
|
Mutation | 2 | 2005 | 29786 | 0.020 |
Why?
|
Cell Adhesion | 2 | 2007 | 3144 | 0.020 |
Why?
|
Neoplasm Proteins | 1 | 2001 | 3703 | 0.020 |
Why?
|
Proteins | 1 | 2004 | 6103 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3597 | 0.020 |
Why?
|
Nerve Tissue Proteins | 1 | 2001 | 4462 | 0.020 |
Why?
|
Receptors, Prostaglandin E, EP4 Subtype | 1 | 2008 | 41 | 0.020 |
Why?
|
Disease Outbreaks | 1 | 2017 | 1772 | 0.020 |
Why?
|
Heart Rate | 1 | 2019 | 4091 | 0.020 |
Why?
|
MAP Kinase Kinase 2 | 1 | 2008 | 96 | 0.020 |
Why?
|
Carrier Proteins | 1 | 2001 | 5021 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7186 | 0.020 |
Why?
|
Logistic Models | 1 | 2022 | 13408 | 0.020 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1998 | 3617 | 0.020 |
Why?
|
Thrombomodulin | 1 | 2007 | 102 | 0.020 |
Why?
|
Carrageenan | 1 | 2006 | 67 | 0.020 |
Why?
|
MAP Kinase Kinase 1 | 1 | 2008 | 337 | 0.020 |
Why?
|
Insulin | 1 | 2021 | 6580 | 0.020 |
Why?
|
New Jersey | 1 | 2005 | 290 | 0.020 |
Why?
|
Amino Acid Motifs | 1 | 2008 | 936 | 0.020 |
Why?
|
Heart | 1 | 1998 | 4467 | 0.020 |
Why?
|
Dinoprostone | 1 | 2008 | 600 | 0.020 |
Why?
|
DNA Methylation | 1 | 2019 | 4286 | 0.020 |
Why?
|
Cardiac Tamponade | 1 | 2005 | 173 | 0.020 |
Why?
|
Sleep, REM | 1 | 1987 | 595 | 0.020 |
Why?
|
Medical Audit | 1 | 2005 | 467 | 0.020 |
Why?
|
Histone Acetyltransferases | 1 | 2006 | 336 | 0.010 |
Why?
|
HIV Reverse Transcriptase | 2 | 1996 | 213 | 0.010 |
Why?
|
HL-60 Cells | 1 | 2004 | 365 | 0.010 |
Why?
|
Macaca mulatta | 2 | 2001 | 2375 | 0.010 |
Why?
|
Macrophage-1 Antigen | 1 | 2004 | 290 | 0.010 |
Why?
|
Umbilical Veins | 1 | 2004 | 433 | 0.010 |
Why?
|
Blood Pressure | 1 | 2019 | 8554 | 0.010 |
Why?
|
Chemokines | 1 | 2008 | 970 | 0.010 |
Why?
|
Digoxin | 1 | 2004 | 250 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2017 | 12026 | 0.010 |
Why?
|
Tetradecanoylphorbol Acetate | 1 | 2004 | 821 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2016 | 4149 | 0.010 |
Why?
|
Israel | 1 | 2005 | 796 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2004 | 677 | 0.010 |
Why?
|
Nuclear Matrix | 1 | 2002 | 28 | 0.010 |
Why?
|
CCAAT-Enhancer-Binding Protein-beta | 1 | 2002 | 103 | 0.010 |
Why?
|
Myogenic Regulatory Factors | 1 | 2002 | 106 | 0.010 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2002 | 137 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2004 | 595 | 0.010 |
Why?
|
Glucose Transporter Type 4 | 1 | 2002 | 250 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2021 | 12261 | 0.010 |
Why?
|
Recombinant Proteins | 2 | 2002 | 6622 | 0.010 |
Why?
|
Postoperative Complications | 1 | 2004 | 15295 | 0.010 |
Why?
|
Viral Regulatory and Accessory Proteins | 1 | 2001 | 159 | 0.010 |
Why?
|
Immunity | 1 | 2007 | 1012 | 0.010 |
Why?
|
Nausea | 1 | 2004 | 673 | 0.010 |
Why?
|
Syncope | 1 | 2004 | 429 | 0.010 |
Why?
|
Viral Load | 2 | 2001 | 3299 | 0.010 |
Why?
|
CD4 Lymphocyte Count | 2 | 1998 | 2559 | 0.010 |
Why?
|
Vomiting | 1 | 2004 | 636 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-sis | 1 | 2002 | 251 | 0.010 |
Why?
|
Polymerase Chain Reaction | 2 | 2004 | 6171 | 0.010 |
Why?
|
Blood Coagulation | 1 | 2007 | 1127 | 0.010 |
Why?
|
Fibrinogen | 1 | 2004 | 894 | 0.010 |
Why?
|
HMGA1a Protein | 1 | 2001 | 64 | 0.010 |
Why?
|
Luciferases | 1 | 2002 | 733 | 0.010 |
Why?
|
Mice, SCID | 1 | 2006 | 2716 | 0.010 |
Why?
|
Interferon Regulatory Factors | 1 | 2002 | 270 | 0.010 |
Why?
|
Retroviridae | 1 | 2002 | 914 | 0.010 |
Why?
|
Sequence Homology, Amino Acid | 1 | 2004 | 2839 | 0.010 |
Why?
|
Cohort Studies | 1 | 2022 | 40561 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2004 | 1526 | 0.010 |
Why?
|
HIV Infections | 2 | 1996 | 16718 | 0.010 |
Why?
|
Fatty Acid-Binding Proteins | 1 | 2001 | 300 | 0.010 |
Why?
|
Platelet-Derived Growth Factor | 1 | 2002 | 625 | 0.010 |
Why?
|
DNA, Complementary | 1 | 2002 | 2050 | 0.010 |
Why?
|
Blood Transfusion | 1 | 2005 | 1301 | 0.010 |
Why?
|
Leucine Zippers | 1 | 1998 | 117 | 0.010 |
Why?
|
Intraoperative Complications | 1 | 2005 | 1198 | 0.010 |
Why?
|
L-Selectin | 1 | 1998 | 213 | 0.010 |
Why?
|
Mice, Inbred CBA | 1 | 1999 | 448 | 0.010 |
Why?
|
HeLa Cells | 1 | 2004 | 3128 | 0.010 |
Why?
|
Embryonic and Fetal Development | 1 | 1998 | 438 | 0.010 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 1998 | 222 | 0.010 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2001 | 880 | 0.010 |
Why?
|
Receptors, Interleukin-2 | 1 | 1998 | 573 | 0.010 |
Why?
|
Proviruses | 1 | 1998 | 318 | 0.010 |
Why?
|
Neutralization Tests | 1 | 1998 | 758 | 0.010 |
Why?
|
COS Cells | 1 | 1998 | 1161 | 0.010 |
Why?
|
Cell Line, Transformed | 1 | 1998 | 898 | 0.010 |
Why?
|
Zalcitabine | 1 | 1996 | 42 | 0.010 |
Why?
|
Myosin Heavy Chains | 1 | 1998 | 414 | 0.010 |
Why?
|
Coronary Artery Bypass | 1 | 2005 | 2289 | 0.010 |
Why?
|
Adult | 3 | 2021 | 214055 | 0.010 |
Why?
|
Didanosine | 1 | 1996 | 153 | 0.010 |
Why?
|
Exons | 1 | 2002 | 2437 | 0.010 |
Why?
|
Adipocytes | 1 | 2002 | 1184 | 0.010 |
Why?
|
Ligands | 1 | 2002 | 3282 | 0.010 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2004 | 3920 | 0.010 |
Why?
|
Epitope Mapping | 1 | 1996 | 311 | 0.010 |
Why?
|
Antigens, Differentiation | 1 | 1998 | 927 | 0.010 |
Why?
|
Depressive Disorder | 1 | 1987 | 3748 | 0.010 |
Why?
|
Lamivudine | 1 | 1996 | 342 | 0.010 |
Why?
|
In Situ Hybridization | 1 | 1998 | 1950 | 0.010 |
Why?
|
Cross Reactions | 1 | 1996 | 841 | 0.010 |
Why?
|
Viremia | 1 | 1996 | 736 | 0.010 |
Why?
|
Collagen | 1 | 2001 | 2689 | 0.010 |
Why?
|
Drug Resistance, Microbial | 1 | 1996 | 862 | 0.010 |
Why?
|
Conserved Sequence | 1 | 1996 | 1202 | 0.010 |
Why?
|
Cholesterol | 1 | 2001 | 2917 | 0.010 |
Why?
|
Models, Genetic | 1 | 2002 | 3494 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2005 | 12245 | 0.010 |
Why?
|
Phosphoproteins | 1 | 2001 | 2440 | 0.010 |
Why?
|
Hospital Mortality | 1 | 2005 | 5317 | 0.010 |
Why?
|
Deoxycytidine | 1 | 1996 | 826 | 0.010 |
Why?
|
Virus Replication | 1 | 1998 | 2534 | 0.010 |
Why?
|
T-Lymphocyte Subsets | 1 | 1998 | 1838 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 1987 | 5027 | 0.010 |
Why?
|
Oligopeptides | 1 | 1996 | 1189 | 0.010 |
Why?
|
Rats, Sprague-Dawley | 1 | 2001 | 8301 | 0.010 |
Why?
|
DNA, Viral | 1 | 1996 | 2225 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2004 | 12959 | 0.010 |
Why?
|
Coronary Angiography | 1 | 1999 | 4577 | 0.000 |
Why?
|
Echocardiography | 1 | 1999 | 5102 | 0.000 |
Why?
|
Survival Rate | 1 | 1999 | 12788 | 0.000 |
Why?
|
Antiviral Agents | 1 | 1996 | 2987 | 0.000 |
Why?
|
Age Factors | 1 | 1998 | 18370 | 0.000 |
Why?
|
Prospective Studies | 1 | 2005 | 53288 | 0.000 |
Why?
|
Reaction Time | 1 | 1987 | 2097 | 0.000 |
Why?
|
Genetic Variation | 1 | 1996 | 6544 | 0.000 |
Why?
|
Psychiatric Status Rating Scales | 1 | 1987 | 6038 | 0.000 |
Why?
|
Electroencephalography | 1 | 1987 | 6150 | 0.000 |
Why?
|